Literature DB >> 2483936

Embryonal tumors from transgenic mouse zygotes carrying human activated c-Ha-ras genes.

M Katsuki1, M Kimura, J Hata, R Takahashi, S Nozawa, M Yokoyama, M Izawa, T Sekiya, S Nishimura, T Nomura.   

Abstract

To investigate the function of activated oncogenes we attempted to create transgenic mice carrying activated human c-Ha-ras genes which have their own promoters. However, we never obtained any transgenic pups which developed to term, because all transgenic embryos were malformed, became developmentally arrested conceptuses or developed embryonic tumors during ontogenesis. The mRNA expression of the transgenes was detected in two tumors obtained after introduction of the DNA fragment containing the activated human c-Ha-ras gene for p21 with valine at the 12th codon or with leucine at the 61st codon. Histological analysis indicated that each tumor consisted of at least three types of cells: two originating from different germ layers (the endoderm in one case and the mesoderm in the other) and the third from extra embryonic ectoderm. It was suggested that the activated human c-Ha-ras gene has a critical effect on the development of tumors in normal embryos as well as in transformation of NIH3T3 cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2483936

Source DB:  PubMed          Journal:  Mol Biol Med        ISSN: 0735-1313


  5 in total

1.  Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys.

Authors:  D L Schaffner; R Barrios; C Massey; E I Bañez; C N Ou; S Rajagopalan; E Aguilar-Cordova; R M Lebovitz; P A Overbeek; M W Lieberman
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

2.  Ras-MAPK signaling promotes trophectoderm formation from embryonic stem cells and mouse embryos.

Authors:  Chi-Wei Lu; Akiko Yabuuchi; Lingyi Chen; Srinivas Viswanathan; Kitai Kim; George Q Daley
Journal:  Nat Genet       Date:  2008-06-08       Impact factor: 38.330

3.  Reprogramming of a melanoma genome by nuclear transplantation.

Authors:  Konrad Hochedlinger; Robert Blelloch; Cameron Brennan; Yasuhiro Yamada; Minjung Kim; Lynda Chin; Rudolf Jaenisch
Journal:  Genes Dev       Date:  2004-08-01       Impact factor: 11.361

4.  Site-specific mutation of the human c-Ha-ras transgene induced by dimethylbenzanthracene causes tissue-specific tumors in mice.

Authors:  S T Doi; M Kimura; M Katsuki
Journal:  Jpn J Cancer Res       Date:  1994-08

Review 5.  RAS pathway regulation in melanoma.

Authors:  Amira Al Mahi; Julien Ablain
Journal:  Dis Model Mech       Date:  2022-03-02       Impact factor: 5.758

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.